Artwork imaging from 370 nm to 1630 nm using a novel multispectral system based on LEDs

The recent use of multispectral systems as a noncontact method for analysis of artworks has already shown promising results. This study explains the application of a novel portable multispectral system based on light-emitting diodes (LEDs) for artwork imaging. This method provides spectral information in a spectral range from 370 to 1630 nm with a 25 cm × 25 cm field of view by using two different image sensors in synchrony with 23 bands of irradiation. The spectral information for each point is estimated and validated using the pseudo-inverse and spline interpolation methods for spectral estimation and three different evaluation metrics. The results of the metrics obtained with both estimation methods show a general good performance of the system over the whole spectral range. The experiments also showed that the selection of the training set for the pseudo-inverse estimation has a great influence in its performance, and thus, it defines whether or not the pseudo-inverse outperforms the spline interpolation method. The system is applied in situ to the study of Catalan art masterpieces, and the results demonstrate the potential of a cost-effective and versatile system using various off-the-shelf elements to reconstruct color information and to reveal features not previously identified. © 2014 Wiley Periodicals, Inc. Col Res Appl, 201

In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy

<p>Abstract</p> <p>Background</p> <p>Gene therapy has the potential to counter problems that still hamper standard HIV antiretroviral therapy, such as toxicity, patient adherence and the development of resistance. RNA interference can suppress HIV replication as a gene therapeutic via expressed short hairpin RNAs (shRNAs). It is now clear that multiple shRNAs will likely be required to suppress infection and prevent the emergence of resistant virus.</p> <p>Results</p> <p>We have developed the first biologically relevant stochastic model in which multiple shRNAs are introduced into CD34+ hematopoietic stem cells. This model has been used to track the production of gene-containing CD4+ T cells, the degree of HIV infection, and the development of HIV resistance in lymphoid tissue for 13 years. In this model, we found that at least four active shRNAs were required to suppress HIV infection/replication effectively and prevent the development of resistance. The inhibition of incoming virus was shown to be critical for effective treatment. The low potential for resistance development that we found is largely due to a pool of replicating wild-type HIV that is maintained in non-gene containing CD4+ T cells. This wild-type HIV effectively out-competes emerging viral strains, maintaining the viral <it>status quo</it>.</p> <p>Conclusions</p> <p>The presence of a group of cells that lack the gene therapeutic and is available for infection by wild-type virus appears to mitigate the development of resistance observed with systemic antiretroviral therapy.</p

Antiviral RNAi: Translating Science Towards Therapeutic Success

Viruses continuously evolve to contend with an ever-changing environment that involves transmission between hosts and sometimes species, immune responses, and in some cases therapeutic interventions. Given the high mutation rate of viruses relative to the timescales of host evolution and drug development, novel drug classes that are readily screened and translated to the clinic are needed. RNA interference (RNAi)-a natural mechanism for specific degradation of target RNAs that is conserved from plants to invertebrates and vertebrates-can potentially be harnessed to yield therapies with extensive specificity, ease of design, and broad application. In this review, we discuss basic mechanisms of action and therapeutic applications of RNAi, including design considerations and areas for future development in the field